Log in
Regional Drug & Therapeutics Centre - RDTC logo
  • Home
  • About
  • Staff
  • Contact Us
  • Manage Account
  • Login
Home » Prescribing Support » New Drug Evaluations

New Drug Evaluations

Document Type Published
Estradiol / progesterone (Bijuve®) for hormone replacement therapy in postmenopausal women New Drug Evaluations May 2022
Estradiol spray for the treatment of menopausal symptoms New Drug Evaluations February 2022
Fast acting insulin lispro for the treatment of diabetes mellitus New Drug Evaluations February 2021
Oral semaglutide for the treatment of type 2 diabetes mellitus New Drug Evaluations October 2020
Brolucizumab for wet age-related macular degeneration New Drug Evaluations September 2020
Levodopa inhalation powder for episodic motor fluctuations in Parkinson’s disease New Drug Evaluations February 2020
Naldemedine for the treatment of opioid induced constipation New Drug Evaluations November 2019
Pentosan for the treatment of bladder pain syndrome New Drug Evaluations October 2019
Insulin glargine plus lixisenatide (Suliqua) for the treatment of T2DM New Drug Evaluations August 2019
Lidocaine/prilocaine spray for premature ejaculation (update) New Drug Evaluations May 2019
1 2 Next »

Follow RDTC on Twitter

Our opening hours

Our opening hours are Monday to Friday: 9am – 5pm

  • Cookie Information
  • Site Disclaimer
  • Terms and Conditions
  • Copyright Notice
  • Privacy Statement